{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05106387",
            "orgStudyIdInfo": {
                "id": "R5459-RT-1956"
            },
            "organization": {
                "fullName": "Regeneron Pharmaceuticals",
                "class": "INDUSTRY"
            },
            "briefTitle": "An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive A Kidney Transplant",
            "officialTitle": "A Noninterventional Extension Study for Patients Treated in Study R5459-RT-1944 With REGN5459 or REGN5458 (BCMA x CD3 Bispecific Antibodies) Who Receive A Kidney Transplant",
            "therapeuticArea": [
                "Nephrology and Renal Diseases"
            ],
            "study": "an-observational-extension-study-for-adult-patients-treated-in-study-rt-who-receive-a-kidney-transplant"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-11",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-10-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-05-21",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-05-21",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-10-22",
            "studyFirstSubmitQcDate": "2021-10-22",
            "studyFirstPostDateStruct": {
                "date": "2021-11-03",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-29",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-30",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Regeneron Pharmaceuticals",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false
        },
        "descriptionModule": {
            "briefSummary": "The primary objective of the study is to assess adverse events (AEs) and serious adverse events (SAEs) in kidney transplant recipients previously treated with REGN5459 or REGN5458 in the R5459-RT-1944 study.\n\nThe secondary objectives of the study are to evaluate each of the following in kidney transplant recipients previously treated with REGN5459 or REGN5458:\n\n* Rates and classification of antibody-mediated and T-cell-mediated kidney allograft rejection\n* Graft survival\n* Allograft function\n* Delayed allograft function\n* Anti-human leukocyte antigen (HLA) alloantibody levels and calculated panel-reactive antibody (cPRA)\n* Emergence of de novo donor-specific antibodies\n* Circulating immunoglobulin (Ig) classes (isotypes)\n* Pharmacokinetics (PK) of REGN5459 or REGN5458"
        },
        "conditionsModule": {
            "conditions": [
                "Chronic Kidney Disease (CKD)"
            ],
            "keywords": [
                "kidney transplant"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 12,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "REGN5459 in study R5459-RT-1944",
                    "description": "Received a kidney transplant and were administered REGN5459 in study R5459-RT-1944.",
                    "interventionNames": [
                        "Other: Noninterventional"
                    ]
                },
                {
                    "label": "REGN5458 in study R5459-RT-1944",
                    "description": "Received a kidney transplant and were administered REGN5458 in study R5459-RT-1944."
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Noninterventional",
                    "description": "No investigational treatment will be given in this noninterventional extension study",
                    "armGroupLabels": [
                        "REGN5459 in study R5459-RT-1944"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of Adverse Events",
                    "timeFrame": "Up to 12 months post-kidney transplant"
                },
                {
                    "measure": "Incidence of Serious Adverse Events",
                    "timeFrame": "Up to 12 months post-kidney transplant"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Incidence of biopsy-proven kidney allograft rejection",
                    "description": "Responsiveness to therapy by 12 months of each of the following types of biopsy-proven kidney allograft rejection according to Banff classification:\n\n* Active antibody-mediated rejection (AMR) (Category 2)\n* Chronic active AMR (Category 2)\n* Acute t-cell-mediated rejection (TCMR) (Category 4)\n* Chronic active TCMR (Category 4)",
                    "timeFrame": "Up to 12 Months"
                },
                {
                    "measure": "Time to diagnosis of biopsy-proven kidney allograft rejection",
                    "description": "Responsiveness to therapy by 12 months of each of the following types of biopsy-proven kidney allograft rejection according to Banff classification:\n\n* Active antibody-mediated rejection (AMR) (Category 2)\n* Chronic active AMR (Category 2)\n* Acute t-cell-mediated rejection (TCMR) (Category 4)\n* Chronic active TCMR (Category 4)",
                    "timeFrame": "Up to 12 Months"
                },
                {
                    "measure": "Responsiveness to therapy by 12 months of biopsy-proven kidney allograft rejection",
                    "description": "Responsiveness to therapy by 12 months of each of the following types of biopsy-proven kidney allograft rejection according to Banff classification:\n\n* Active antibody-mediated rejection (AMR) (Category 2)\n* Chronic active AMR (Category 2)\n* Acute t-cell-mediated rejection (TCMR) (Category 4)\n* Chronic active TCMR (Category 4)",
                    "timeFrame": "Up to 12 Months"
                },
                {
                    "measure": "Incidence of graft loss",
                    "description": "Incidence of graft loss (defined as becoming dialysis-dependent) by 12 months",
                    "timeFrame": "Up to 12 Months"
                },
                {
                    "measure": "Time to graft loss",
                    "description": "Time to graft loss (defined as becoming dialysis-dependent) by 12 months",
                    "timeFrame": "Up to 12 Months"
                },
                {
                    "measure": "Change in estimated glomerular filtration rate (eGFR) over time",
                    "timeFrame": "Up to 12 Months"
                },
                {
                    "measure": "Incidence of delayed graft function",
                    "description": "Incidence of delayed graft function (defined as the use of dialysis within 7 days posttransplant)",
                    "timeFrame": "Up to Day 7"
                },
                {
                    "measure": "Percent Change in anti-HLA alloantibodies",
                    "description": "Percent Change in anti-HLA alloantibodies (SAB assay) compared with pretransplant levels at 2, 3, 6, and 12 months, and at the time of suspected clinical episodes of allograft rejection",
                    "timeFrame": "Up to 12 months"
                },
                {
                    "measure": "Mean Fluorescence Intensity Change in anti-HLA alloantibodies",
                    "description": "Mean Fluorescence Intensity (MFI) Change in anti-HLA alloantibodies (SAB assay) compared with pretransplant levels at 2, 3, 6, and 12 months, and at the time of suspected clinical episodes of allograft rejection",
                    "timeFrame": "Up to 12 months"
                },
                {
                    "measure": "Change in Calculated panel-reactive antibody (cPRA) over time",
                    "timeFrame": "Up to 12 Months"
                },
                {
                    "measure": "Percent Change in donor-specific anti-HLA alloantibodies",
                    "description": "Percent Change in donor-specific anti-HLA alloantibodies compared with recipient pre-transplant anti-HLA alloantibody levels",
                    "timeFrame": "Up to 12 Months"
                },
                {
                    "measure": "Mean Fluorescence Intensity Change in donor-specific anti-HLA alloantibodies",
                    "description": "Mean Fluorescence Intensity Change in donor-specific anti-HLA alloantibodies compared with recipient pre-transplant anti-HLA alloantibody levels",
                    "timeFrame": "Up to 12 Months"
                },
                {
                    "measure": "Incidence of de novo anti-HLA alloantibody development",
                    "description": "Cumulative incidence of de novo anti-HLA alloantibody development by SAB assay by 12 months",
                    "timeFrame": "Up to 12 Months"
                },
                {
                    "measure": "Serum Concentrations of Ig classes (IgG, IgA, and IgM) over time",
                    "timeFrame": "Up to 12 Months"
                },
                {
                    "measure": "Percent change from baseline of circulating serum concentrations of Ig classes",
                    "description": "Percent change from baseline of circulating serum concentrations of Ig classes (IgG, IgA, and IgM)",
                    "timeFrame": "Up to 12 Months"
                },
                {
                    "measure": "Serum Concentration of R5458",
                    "timeFrame": "Up to 12 Months"
                },
                {
                    "measure": "Serum Concentration of R5459",
                    "timeFrame": "Up to 12 Months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Received at least 1 dose of treatment with REGN5459 or REGN5458 in study R5459-RT-1944\n* Received, or scheduled to receive after acceptable crossmatching, a kidney transplant while enrolled in study R5459-RT-1944\n* Willing and able to comply with clinic visits and study-related procedures\n* Provide informed consent signed by study patient or legally acceptable representative\n\nExclusion Criteria:\n\n* There are no exclusion criteria for this study.\n\nNote: Other protocol defined Inclusion/Exclusion criteria may apply",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "70 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "This study is designed to collect safety and outcomes data in patients aged 18 through 70 years who receive a kidney transplant and were administered REGN5459 or REGN5458 in study R5459- RT-1944.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Clinical Trials Administrator",
                    "role": "CONTACT",
                    "phone": "844-734-6643",
                    "email": "clinicaltrials@regeneron.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Clinical Trial Management",
                    "affiliation": "Regeneron Pharmaceuticals",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Cedars-Sinai Medical Center",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90048",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "University of California Irvine",
                    "status": "RECRUITING",
                    "city": "Orange",
                    "state": "California",
                    "zip": "92868",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.78779,
                        "lon": -117.85311
                    }
                },
                {
                    "facility": "University of California San Francisco",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94143",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "Yale University School of Medicine Transplant Surgery",
                    "status": "RECRUITING",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06519",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "Northwestern University Comprehensive Transplant Center",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Johns Hopkins Hospital",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21224",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "New York University Langone Health - Transplant Institute",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10016",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "University of Pennsylvania-Penn Transplant Institute",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000051436",
                    "term": "Renal Insufficiency, Chronic"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000051437",
                    "term": "Renal Insufficiency"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "asFound": "Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26717",
                    "name": "Renal Insufficiency, Chronic",
                    "asFound": "Chronic Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26718",
                    "name": "Renal Insufficiency",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M20194",
                    "name": "Antibodies, Bispecific",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}